MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Acute Myeloid Leukemia Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,888 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,888 works in the cohort · of 4,299,418page 9 of 58

Labels cover 3 of 2,888 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,888 of 2,888 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affaboutunlabeled
Enasidenib Plus Azacitidine Significantly Improves Complete Remission and Overall Response Compared with Azacitidine Alone in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with Isocitrate Dehydrogenase 2 (IDH2) Mutations: Interim Phase II Results from an Ongoing, Randomized Study
Courtney D. DiNardo, Andre C. Schuh, Eytan M. Stein, Pau Montesinos Fernández, Andrew H. Wei, Stéphane de Botton +11 more
2019· article· en· Blood· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
45
citations
affno abstractunlabeled
Acute Leukemias in Children with Down Syndrome
C. Michel Zwaan, Dirk Reinhardt, Johann Hitzler, Paresh Vyas
2010· review· en· Hematology/Oncology Clinics of North America· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
45
citations
affaboutunlabeled
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186
David MacDonald, Sarit Assouline, Joseph Brandwein, Suzanne Kamel‐Reid, Elizabeth A. Eisenhauer, Stephen Couban +4 more
2012· article· en· Leukemia & lymphoma/Leukemia and lymphoma· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
45
citations
affno abstractunlabeled
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs
Mohsen Hosseini, Véronique Voisin, Ali Chegini, Angelica Varesi, Séverine Cathelin, Dhanoop Manikoth Ayyathan +21 more
2025· article· en· Nature· Medicine
distilled prediction:candidate · research_integrityconsensus · none
44
citations
affunlabeled
Aleukemic Congenital Leukemia Cutis
Antonio Torrelo, Luís Madero, Imelda G. Mediero, Antonio Navarro Baño, Antonio Zambrano
2004· article· en· Pediatric Dermatology· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
44
citations
fundno affunlabeled
Treatment of Acute Leukemias
J Bernard, C Jacquillat, M Weil
2003· article· en· Humana Press eBooks· Medicine
distilled prediction:candidate · noneconsensus · none
44
citations
affunlabeled
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
David A. Jacobsohn, Michael R. Loken, Mingwei Fei, Alexia Adams, Lisa Eidenschink Brodersen, Brent R. Logan +43 more
2018· article· en· Biology of Blood and Marrow Transplantation· Medicine
distilled prediction:candidate · noneconsensus · none
42
citations
← previousnext →

How this was built: Screen · Findings · About